The First Hospital of Jilin University — Changchun, Jilin

Public research footprint of The First Hospital of Jilin University, compiled from the ClinicalTrials.gov public registry.

877

Registered studies

375

Active

197

Recruiting now

351

Completed

Stopped or withdrawn

Most-studied conditions

Breast Neoplasms · Diffuse Large B-Cell Lymphoma · Triple Negative Breast Neoplasms · Advanced Solid Tumors

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT06624670 — A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma… (Recruiting)
NCT06880744 — A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The First Hospital of Jilin University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.